Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

NCT01042704 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: Bendamustine
DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: Aspirin
DRUG: Prophylaxis
DRUG: Antibiotic
OTHER: Biweekly Follow Up
OTHER: Cyclical Follow Up
OTHER: Restaging
OTHER: Post-Treatment Follow Up

Sponsor

Robert Redner, MD

Collaborators

[object Object]